1375P Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC)
暂无分享，去创建一个
M. Buyse | M. Parmar | D. Dearnaley | I. Thompson | C. Tangen | M. Morris | P. Verhagen | C. Sweeney | Arpita Roy | S. Halabi | J. Tierney | L. Rydzewska | N. James | T. Goto | M. Carducci | M. Hussain | M. Smith | W. Xie | P. Godolphin | G. Gravis Mescam